June 2, 2016
“Fearing Drugs’ Rare Side Effects, Millions Take Their Chances With Osteoporosis,” written by Gina Kolata, was published on the front page of the New York Times on June 2. This timely article comes after an urgent call by ASBMR, NBHA, and NOF stressing the importance of taking action to treat patients with osteoporosis while weighing the risk for rare side effects associated with the medication. Recent research published in JBMR revealed that millions of Americans suffering from osteoporosis are going unscreened and untreated leading to a rise in repeated fractures was highlighted in the New York Times piece, including the articles “Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996–2012: An Ecological Analysis” and “Osteoporosis Medication Use After Hip Fracture in U.S. Patients between 2002 and 2011.”
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details